发现了蛋白质氨酸甲基转移酶6 (PRMT6) 的第一类降解剂

Hongling Yang1, Qiangsheng Zhang1, Shuyan Zhou1

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, and Collaborative Innovation Center for Biotherapy, 17#3rd Section, Ren Min South Road, Chengdu 610041, China.

PubMed
概括

研究人员开发了SKLB-0124,一种针对PRMT6 (蛋白质氨酸甲基转移酶6) 的新型蛋白质降解剂. 这种新的候选药物有效地抑制癌细胞增殖并诱导细胞亡,显示出癌症治疗的前景.